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Results: The treatment of Centella spp. revealed signiﬁcant
reduction of lipid droplet deposition anddecrease of the size of
lipid droplet in the adipocyte. Molecular biological experiment
suggested that the treatment of Centella spp. signiﬁcantly
inhibited the expression of Trib 3: more than 100% of Trib3
was decreased compared to the control. On the contrary, the
express ion of adiponectin, CTRP 6 and Glut 4 were consider-
ably increased by the treatment of these herbal extracts.
Conclusion: These results suggest that the adaptation of
these herbal extracts have signiﬁcant potential to inhibit fatal
etiological triggering of cardiovascular disease causing by the
obesity. Hence, these herbal extract might be a therapeutic
target to ﬁght against obesity and its associated diseases in
modern industrial countries.
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Purpose: Inulin from Cichorium intybus L., a kind of Chi-
nese Materia Medica, is potential therapeutics that act alone
or supplement on serummetabolic parameters in the preven-
tion and treatment of obesity. The present investigation was
undertaken to study the protective and anti-obesity effects of
inulin from Cichorium intybus L. on serum lipid concentra-
tion and abdominal fat pad mass in quail model induced by
protein and purine rich diet.
Methods: Quails were divided randomly into 5 groups
according to bodyweight: normal group,model group, positive
control group and chicory inulin high and low dosage groups.
The normal group was fed with the common feedstuff, and
the other groups were fed with protein and purine rich diet.
Positive control group was given Fenoﬁbrate 100mg/ (kg•d).
Chicory inulin groups were given inulin 10, 5 g/(kg•d) respec-
tively. All quails were given distilled water. Serum triglyceride
(TG), abdominal fat pad mass and acetyl-Coa carboxlyase
(ACC), fatty acid synthase (FAS) activity were determined.
Results: Compared with normal group serum TG level of
model group was signiﬁcantly higher on 21d and 28d and
abdominal fat pad mass increased on 28d. Compared with
model, fenoﬁbrate decreased serum TG level on 21d and 28d.
Chicory inulin decreased TG signiﬁcantly and abdominal fat
pad mass on 28d. ACC protein expression and fatty acid syn-
thase (FAS) activities were decreased in chicory inulin groups
signiﬁcantly. However, serum cholesterol (TC), low-density
lipoprotein (LDL) andhigh-density lipoprotein (HDL) levelwere
not signiﬁcantly altered by treatment.
Conclusion: Inulin of Cichorium intybus L. signiﬁcantly
improved lipid metabolism of diet induced abdominal obe-
sity in quails. The possible mechanism of anti-obesity activity
appears to be either decreasing ACC protein expression and
FAS activity, or decreasing serum TG level property.
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Aqueous extract of solanum nigrum
activated programmed cell death and
enhanced cisplatin/doxorubicin induced
cytotoxicity on human hepatocellular carc
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Purpose: In traditional Chinese medicine, the aqueous
extract of solanum nigrum (AESN) is a key ingredient pre-
sented in various formulas for dealing with cancer patients.
Recent studies suggested AESN is capable of activating pro-
grammed cell death inmany human cancer types both in vitro
and in vivo. This study is to examine the antitumor potential
of AESN in integrationwith standard chemotherapeutic drugs,
cisplatin and doxorubicin, on human hepatocellular cancer
cells.
Methods: Human hepatocellular carcinoma cells, Hep3B
and HepJ5, were treated by 0 to 10mg/ml AESN for 48 hr to
determine the cytotoxicity. Hep3B andHepJ5 cellswere treated
with 0, 0.5 or 1.0mg/ml AESN with 0 to 20M cisplatin or 0
to 10M doxorubicin respectively for 48 hr to evaluate the
combined cytotoxic effects. The activation of programmed cell
deathmarkers, caspase-3 and caspase-7 for apoptosis and LC3
A/B for autophagy were also determined by western blotting
assay on AESN-treated cells.
Results: The half-maximum inhibitory concentrations
(IC50s) of AESN on Hep3B and HepJ5 cells were 0.96 and
0.97mg/ml respectively. The co-treatment of AESN (0.5mg/ml)
reduced the IC50s of cisplatin from 6.75 to 2.75M on Hep3B
cells and 8.71 to 2.84M on HepJ5 cells, whereas the IC50s
of doxorubicin were reduced from 4.65 to 1.31M on Hep3B c
ells, and 6.39 to 1.42MonHepJ5 cells. AESN induced the accu-
mulation of LC3 A/B II and the cleavage of caspase-7 but not
caspase-3 on Hep3B and HepJ5 cells suggested the induction
of autophagic and apoptotic cell death by AESN.
Conclusion: This study indicated that AESN activated pro-
grammed cell death including caspase-7 related apoptosis and
autophagy to enhance cytotoxicity induced by cisplatin and
doxorubicin in human hepatocellar carcinoma cells. These
experimental evidences suggested AESN is a potential ingre-
dient to develop the novel integrated chemotherapy with
cisplatin or doxorubicin on treating hepatocellular carcinoma.
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